Fr Prophylaxe, Beratung und Therapie
Nuclear magnetic resonance detects phosphoinositide 3-kinase/Akt-independent traits common to pluripotent murine embryonic stem cells and their Malignant counterparts
Montgomery SA, Thal LJ, Amrein R
9.11.1 Company Overview 9.11.2 Product Benchmarking List of Tables Table 2 L -carnitine market estimates and forecasts, by bioprocess, 2017 - 2028 (Tons) (USD Thousand) Table 3 L -carnitine market estimates and forecasts, by food & pharmaceutical grade, 2017 - 2028 (Tons) (USD Thousand) Table 4 L -carnitine market estimates and forecasts, by feed grade, 2017 - 2028 (Tons) (USD Thousand) Table 5 L -carnitine market estimates and forecasts, by animal feed, 2017 - 2028 (Tons) (USD Thousand) Table 6 L -carnitine market estimates and forecasts, by healthcare products, 2017 - 2028 (Tons) (USD Thousand) Table 7 L -carnitine market estimates and forecasts, by functional food & beverages, 2017 - 2028 (Tons) (USD Thousand) Table 8 L -carnitine market estimates and forecasts, by medicines, 2017 - 2028 (Tons) (USD Thousand) Table 9 North America L-carnitine market estimates and forecasts, 2017 - 2028 (Tons) (USD Thousand) Table 10 North America L-carnitine market estimates and forecasts, by process, 2017 - 2028 (Tons) Table 11 North America L-carnitine market estimates and forecasts, by process, 2017 - 2028 (USD Thousand) Table 12 North America L-carnitine market estimates and forecasts, by product, 2017 - 2028 (Tons) Table 13 North America L-carnitine market estimates and forecasts, by product, 2017 - 2028 (USD Thousand) Table 14 North America L-carnitine market estimates and forecasts, by application, 2017 - 2028 (Tons) Table 15 North America L-carnitine market estimates and forecasts, by application, 2017 - 2028 (USD Thousand) Table 16 U.S
